RayzeBio Revenue and Competitors

Claim your profile



Growjo Ranking



Estimated Revenue & Valuation

  • RayzeBio's estimated annual revenue is currently $18.6M per year.(i)
  • RayzeBio's estimated revenue per employee is $155,000
  • RayzeBio's total funding is $258M.

Employee Data

  • RayzeBio has 120 Employees.(i)
  • RayzeBio grew their employee count by 9% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

Leader in targeted radiopharmaceuticals to improving cancer patient survival. Broad pipeline of innovative drugs against solid tumor targets



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





RayzeBio News

2021-06-16 - RayzeBio Snags $108M for Cancer Drug Efforts

San Diego-based RayzeBio, a pharmaceuticals company which says it is developing targeted radiopharmaceutical drugs for cancer, has raised $108M in its Series C funding. The company said it has now raised a total of $258M. The new funding was led by Venrock Healthcare Capital Partners and also in ...

2021-06-15 - RayzeBio Secures $108 Million Series C Financing to Drive Forward Its Pipeline of Targeted Radiopharmaceuticals for Cancer

RayzeBio, Inc., which is discovering and developing a broad pipeline of innovative targeted radiopharmaceutical drugs for cancer, today announced a $108 million Series C financing led by Venrock Healthcare Capital Partners alongside new investors Perceptive Advisors, Vivo Capital, Acuta Capital ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

RayzeBio Executives

Arvind KushChief Financial Officer
Deborah CharychScientific Founder, Chief Technology Officer, Advisor
Susan MoranChief Medical Officer
Ken SongPresident and CEO
Kimberly MaSVP of Clinical Operations
Derek ColeSenior Vice President Chemistry, Head of Discovery
Eric BischoffSenior Vice President, Development and Operations at RayzeBio, Inc.
Juan LiVP, Biometrics
Ken SongPresident and CEO
Eric BischoffSVP Development & Operations
Gary LiSenior Vice President, Biology & Translational Medicine
Nicholas SmithSVP, Chemistry Innovation
Abhi BhatSVP, Chemistry & Head of Discovery